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Abstract 
Generally, autoimmune diseases are more prevalent in females than males. Various predisposing factors, including 
female sex hormones, X chromosome genes, and the microbiome have been implicated in the female bias of autoim-
mune diseases. During embryogenesis, one of the X chromosomes in the females is transcriptionally inactivated, in 
a process called X chromosome inactivation (XCI). This equalizes the impact of two X chromosomes in the females. 
However, some genes escape from XCI, providing a basis for the dual expression dosage of the given gene in the 
females. In the present review, the contribution of the escape genes to the female bias of autoimmune diseases will 
be discussed.
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Background
Generally, autoimmune diseases are more prevalent in 
females than males. Various predisposing factors, includ-
ing female sex hormones, X chromosome genes, and the 
microbiome have been implicated in the female bias of 
autoimmune diseases. During embryogenesis, one of 
the X chromosomes in the females is transcriptionally 
inactivated, in a process called X chromosome inactiva-
tion (XCI). This equalizes the impact of two X chromo-
somes in the females. However, some genes escape from 
XCI, providing a basis for the dual expression dosage of 
the given gene in the females. In the present review, the 
contribution of some escape genes to the female bias of 
autoimmune diseases was discussed.
The current literature provides evidence in the contri-
bution of a number of the escape genes, including CD40L, 
CD99, LAMP-2, IRAK-1, TLR7, USP27X, DDX3X, 
CXORF21 and XIAP, in the autoimmunity. Current 
literature also confirms contribution of some escapes 
genes including CD40L, IRAK-1, TLR7, CXORF21 and 
XIAP to the female bias of autoimmune diseases espe-
cially SLE disease. However, more studies are required to 
evaluate contribution of these genes in the female bias of 
SLE using animal model of the disease and the efficacy of 
therapeutic interventions against these molecules. Next 
experiments are also necessary to address attribution of 
these genes to the female bias of other autoimmune dis-
eases rather than SLE. Finally, investigating role of the 
other escape genes such as USP27X and DDX3X in the 
sex-bias of autoimmune diseases such as SLE, RA, MS 
may help to discover further mechanisms involved in the 
female bias of autoimmunity and consequently in devel-
oping more effective treatments and sensitive diagnostics 
of patients with autoimmune diseases.
X chromosome inactivation (XCI)
The hypothesis of XCI was introduced by Mary Lyon 
in 1961. In the XCI process, one of the X chromo-
somes in women is inactivated in which DNA is tightly 
condensed into the heterochromatin structure and 
becomes transcriptionally inactive. As a result, XCI 
equalizes the impact of the presence of two X chromo-
somes in females (Disteche and Berletch 2015). XCI is 
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a random process in which one of the X chromosomes 
during embryogenesis is randomly selected and inac-
tivated (Patrat et  al. 2013). It is an irreversible pro-
cess and, the selected allele will be remained inactive 
throughout the life span (Patrat et al. 2013).
XCI is a regulated multi-step process initiated and 
continued by the following steps (1) Enumeration of X 
chromosomes (2) Selection of one chromosome for the 
XCI process (3) Initiation of XCI process (4) mainte-
nance of XCI in the subjected genes (Lu et  al. 2017). 
XCI process is started and controlled from X-inacti-
vation center (XIC) in which a long non-coding ribo-
nucleic acid (lncRNA) designated X-inactive specific 
transcript (XIST), plays a central role in the process. 
XIST mediates all aspects of XCI, including coating 
of the chromosome, elimination of RNA polymerases 
from deoxyribonucleic acid (DNA), removal of the 
active histone modifications allowing for transcription 
from DNA, inclusion of the repressive histone modi-
fications into DNA resulting in transcriptional repres-
sion, methylation of DNA and tethering of the inactive 
X chromosome to the nuclear periphery (Fig.  1) (Lu 
et al. 2017).
XCI is initiated by binding of XIST to XIC on the 
X-chromosome and subsequent spreading along the 
chromosome. Minimal diffusion to the nucleoplasm 
occurs, ensuring the silencing does not spill over to 
the other chromosomes (Lu et  al. 2017). In addition 
to XIST, various proteins which bind to the distinct 
sequence regions of XIST, cooperate with it in XCI 
process. Heterogeneous nuclear ribonucleoprotein 
U family of the proteins are implicated in XIST and 
coat the intended X chromosome for XCI (Lu et  al. 
2017). The polycomb repressive complexes (PRCs) 
proteins, including PRC1 and PRC2, play crucial roles 
in the transcriptional silencing through promotion of 
various histone modifications, including H2AK119 
mono-ubiquitination (H2AK119ub) and H3K27 tri-
methylation (H3K27me3). These histone modifications 
exert transcriptional repression of the chromosome 
(Tamburri 2020; Pan et  al. 2018). Lamin B receptor 
protein may mediate tethering of the inactivated X 
chromosome to the nuclear periphery appeared as the 
Barr body, the inactive X chromosome in the cell with 
more than one X chromosome (Lu et al. 2017).
Escape from XCI
Evaluation of inactive X chromosomes in humans shows 
approximately 15% of the genes regularly escape from 
XCI, while around 15% of the other genes variably escape, 
as XCI escape is permanent in some genes (15%) and spa-
tial in the others (15%) (Posynick and Brown 2019). The 
escaped genes are different among various tissues and 
individuals. This renders multiple tissues and individuals 
to be different in the extent of susceptibility to the diseases 
if the escaped gene is implicated in the disease pathogen-
esis (Peeters et al. 2014). Besides, a mosaics pattern of XCI 
either in paternal or maternal X chromosome is observed 
in the cells of female body (Posynick and Brown 2019).
Conventionally, X chromosome genes with a homolo-
gous gene on the Y chromosome have been considered to 
escape from XCI, allowing for the dosage compensation in 
the females (Posynick and Brown 2019). However, almost 
many escape genes are devoid of a functional homologue 
on the Y chromosome. Some of these genes render the 
female gender with a specific benefit. For example, these 
genes are implicated in the success of the pregnancy 
(Posynick and Brown 2019). The neighborhood elements 
of a gene also contribute to its inactivation or escape pat-
tern. An enrichment of Alu elements and the other simple 
repeats was identified at approximate of the escape genes, 
while L1 and L2 types of long interspersed nuclear ele-
ments, were associated with the genes subjected to XCI 
(Posynick and Brown 2019; Peeters et al. 2014). Moreover, 
the presence of the boundary elements between escape and 
subject genes may prevent spreading of the silencing into 
the neighboring regions. The regulatory role of CCCTC-
binding factor, a transcription factor involved in the tran-
scriptional regulation, insulator activity and regulation of 
three-dimensional structure of chromatin (Kim et al. 2015), 
in the boundary regions has been identified (Posynick and 
Brown 2019; Peeters et al. 2014).
A recent report by Katsir et  al. identified a number of 
24 genes, corresponding to 10.3% of all expressed genes 
in the X chromosome, which escape from XCI (Wainer 
Katsir and Linial 2019). The others cited another set of 
the escape genes (Odhams 2019; Carrel and Willard 1999; 
Wang 2016). A summary of these genes mostly involved in 
innate and adaptive immune response is given in Table 1. 
XCI escape may provide a basis for more susceptibility of 
women than men to the autoimmune diseases (Fairweather 
and Rose 2004), as the prone women can produce a given 
(See figure on next page.)
Fig. 1 Contribution of XIST in XCI. XIST coats the chromosome and mediates various aspects of XIC, including elimination of RNA polymerases from 
DNA, removal of the active histone modifications from the chromosome, inclusion of the repressive histone modifications into the chromosome, 
methylation of DNA and tethering of the inactive X chromosome to the nuclear periphery. DNA: Deoxyribonucleic acid; XCI: X chromosome 
inactivation; XIST: X-inactive specific transcript; RNA: Ribonucleic acid
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pathogenic protein in double doses than men due to its 
expression from two X chromosome (Fig. 2). In the follow-
ing sections, the contribution of the genes with the possible 
implications in autoimmune diseases will be reviewed.
Cluster of differentiation 40 ligand (CD40L)
CD40L is a type II transmembrane protein which is 
belonged to tumor necrosis factor (TNF) family of 
cytokines. It is a 261 amino acids protein with a molec-
ular weight of 35 KDa containing an amino-terminal 
intracellular domain, a transmembrane domain, and a 
carboxy-terminal extracellular domain (Laman et  al. 
1996).
The signaling cascade of the cluster of differentiation 
40 (CD40), upon its interaction with CD40L, is initi-
ated by the recruitment of TNF receptor-associated 
factor (TRAF) adaptor proteins to the cytoplasmic tail 
of CD40. Various members of the TRAF family, includ-
ing TRAF-1, TRAF-2, TRAF-3, TRAF-5, and TRAF-6 
were detected to associate with the receptor either 
directly or indirectly. The outcome is the activation of 
various transcription factors, including nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB), 
activator protein 1 (AP-1) and nuclear factor of activated 
T cells (NFAT) (Schonbeck and Libby 2001).
CD40 engagement on dendritic cells (DCs) by CD40L 
on CD4+ T cells, increases expression of major his-
tocompatibility complex (MHC) molecules as well as 
costimulatory signals including, cluster of differentia-
tion 80 (CD80), cluster of differentiation 86 (CD86) and 
cytokines on DCs. These enhancements which are called 
licensing, in turn, increase CD4+ T cell responses (Ma 
and Clark 2009; Abbas et al. 2017). Licensing also renders 
DCs to induce activation of naïve CD8+ T cells and pro-
mote their priming towards effector cytotoxic T lympho-
cytes (CTLs). This explains the need for CD4+ T cells in 
the activation and formation of CTL responses (Andrade 
et  al. 2005). By these ways, CD40-CD40L interaction 
amplifies cellular immune responses exerted by CD4+ 
and CD8+ T cells. On the other hand, regulatory DCs do 
not express CD40 despite the presence of stimulatory sig-
nals in the cell culture system (Ma and Clark 2009). This 
subset of DCs produces a great amount of the immuno-
suppressive cytokines, including interleukin-10 (IL-10) 
Table 1 A list of the genes escaped from X chromosome inactivation
- Gene symbol Gene nomenclature Aliases for the gene Reference numbers
1 CD99 Cluster of differentiation 99 HBA71, MIC2, MIC2X, MIC2Y, MSK5X, Xg blood 
group
Wainer Katsir and Linial (2019)
2 LAMP2 Lysosomal associated membrane protein 2 CD107b, LAMPB, LGP110, LGP-96, DND Wainer Katsir and Linial (2019)
3 USP27X Ubiquitin specific peptidase 27 X-linked Deubiquitinating enzyme 27, USP22L, USP27, 
Ubiquitin Carboxyl-Terminal Hydrolase 22-Like, 
Ubiquitin Carboxyl-Terminal Hydrolase 27, 
MRX105
Wainer Katsir and Linial (2019)
4 XIAP X-linked inhibitor of apoptosis API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, HIAP-3 Wainer Katsir and Linial (2019)
5 DDX3X DEAD-BOX helicase 3 X-linked DBX, DDX14, DDX3, HLP2, CAP-Rf, MRX102 Wainer Katsir and Linial (2019)
6 XIST X inactive specific transcript DXS1089, DXS399E, LINC00001, NCRNA00001, 
SXI1, swd66
Wainer Katsir and Linial (2019)
7 DMD Dystrophin BMD, CMD3B, DXS142, DXS164, DXS206, 
DXS230, DXS239, DXS268, DXS269, DXS270, 
DXS272, MRX85
Wainer Katsir and Linial (2019)
8 TMSB4X Thymosin beta 4 X-linked FX, PTMB4, TB4X, TMSB4 Wainer Katsir and Linial (2019)
9 CSF2RA Colony stimulating factor 2 receptor subunit 
alpha
CD116, CDw116, CSF2R, CSF2RAX, CSF2RAY, 
CSF2RX, CSF2RY, GM-CSF-R-alpha, GMCSFR, 
GMR, SMDP4
Wainer Katsir and Linial (2019)
10 IL3RA Interleukin 3 receptor subunit alpha CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra Wainer Katsir and Linial (2019)
11 PRKX Protein KINASE X-linked PKX1, EC 2.7.11.1, Protein Kinase PKX1 Wainer Katsir and Linial (2019)
12 OTC Ornithine carbamoyltransferase OCT29D, OTCase Wainer Katsir and Linial (2019)
13 IRAK1 interleukin 1 receptor associated kinase 1 IRAK, pelle, Odhams (2019)
14 TLR7 toll-like receptor 7 TLR7-like Odhams (2019)
15 CXorf21 Chromosome X open reading frame 21 FLJ11577, Uncharacterized protein CXorf21 Odhams (2019)
16 TMEM187 Transmembrane protein 187 CXorf12, DXS9878E, ITBA1, Protein ITBA1 Odhams (2019)
17 CD40L CD40 ligand CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, 
TNFSF5, TRAP, Gp39, HCD40L
Wang (2016)
18 CXCR3 C-X-C motif chemokine receptor 3 CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, 
MigR
Wang (2016)
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and transforming growth factor-beta (TGF-β) and drives 
the generation of regulatory T cells (Tregs) (Ma and 
Clark 2009).
CD40 ligation on B cells influences various aspects 
of humoral immunity. The ligation of CD40 promotes 
B cell activation and proliferation. Upregulation of 
MHC II molecules and costimulatory ligands, CD80 
and CD86, was detected on B cells (Karnell et al. 2019). 
Crucial events which ultimately lead to germinal cent-
ers (GCs) formation, are triggered after the interaction 
between CD40 on B cells and CD40L on T cells. This 
interaction promotes B cell proliferation in the dark 
zoon of GCs (Abbas et al. 2017). Moreover, the prolifer-
ated cells located in the light zoon of GCs, are induced 
to express the enzymes, including activation-induced 
cytidine deaminase and uracil-N glycosylase, required 
for class switching and affinity maturation process of the 
antibodies (Abbas et al. 2017). CD40-CD40L interaction 
is implicated in the development of follicular dendritic 
cells (FDCs) which are crucial for the maintenance of 
follicles architecture in the secondary lymphoid organs 
as well as in the selection events of B cells undergone 
affinity maturation process (Sullivan 1996). Accordingly, 
patients with hyper IgM syndrome which are deficient in 
CD40 or CD40L, demonstrate a defect in GCs formation, 
accompanied by the impaired formation of FDCs (Sulli-
van 1996). In summary, CD40 ligation on B cells, contrib-
utes to GCs formation in which B cell proliferation and 
differentiation to the antibody-producing cells as well as 
isotype switching and affinity maturation of the antibod-
ies are conducted.
Similar to DCs, macrophages also serve as antigen-pre-
senting cells for T cells. Thus, the similar licensing pro-
cess assumed to DCs, can be attributed to macrophages. 
This enhances the immunostimulatory activity of mac-
rophages leading to the efficient activation of T cell 
Fig. 2 A schematic diagram of contribution of escape genes to the female bias of autoimmune diseases. Prone females can express the escape 
genes in double doses compared to males due to its expression from two X chromosome. CD40L: Cluster of differentiation 40 ligand; CD99: Cluster 
of differentiation 99; CXORF21: Chromosome X open reading frame 21; IRAK-1: Interleukin-1 receptor-associated kinase-1; XIAP: X-linked inhibitor of 
apoptosis protein; TLR7: Toll-like receptor 7; USP27X: Ubiquitin carboxyl-terminal hydrolase 27
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responses. Accordingly, macrophage CD40 signaling are 
attributed to the pathogenesis of various human autoim-
mune disease and animal models of autoimmunity (Sut-
tles and Stout 2009). Moreover, a T cell-independent 
pathway has been discovered for the activation of mac-
rophages. Andrade et al. detected CD40 stimulated-mac-
rophages infected with an intracellular infection agent, 
Toxoplasma Gondi, were able to destroy the pathogen 
despite the lack of interferon-gamma (IFN-γ) or reac-
tive nitrogen radicals. The microbicidal effect of these 
infected macrophages was dependent on Tumor necrosis 
factor-alpha (TNF-α) suggesting CD40 engagement on 
macrophages triggers TNF-α production (Andrade et al. 
2005). In the following sections, a review of the literature 
demonstrating participation of CD40-CD40L interac-
tion in the pathogenesis of autoimmune diseases will be 
presented.
In rheumatoid arthritis (RA), increased number of 
CD4+ CD40L+ T cells expressing high CD40L tran-
scripts was detected. When the patients were stratified 
according to the disease activity, a significant correlation 
was found between CD40L transcript levels and clinical 
activity of the disease in the patients (Román-Fernández 
2019). Ligation of CD40 on synovial tissues of the RA 
patients, by CD40L+ T cells induced production of TNF-
α. These results suggest the activation of CD40 on syno-
vial tissues promotes the generation of the inflammatory 
microenvironment in the surrounding tissues through 
the production of proinflammatory cytokines (Harigai 
1999). According, the production of TNF-α was detected 
from monocytes obtained from the synovial tissues of 
RA patients, upon stimulation with CD40L (Sekine et al. 
1998).
A certain allele of CD40 has been identified in asso-
ciation with the higher risk of systemic lupus erythe-
matosus (SLE) in the polymorphism studies (Devi et  al. 
1998). Accordingly, increased expression of CD40L was 
observed, at least in some SLE patients. T helper (Th) 
cells from SLE patients continued to express a high level 
of CD40L, while CD40L expression in Th cells from the 
control group was diminished at 24 and 48 h of the stim-
ulation. Moreover, Th cells from SLE patients, induced 
the higher level of costimulatory molecules in B cells in 
an in vitro co-culture system (Koshy et al. 1996). Desai-
Mehta et  al. identified a similar finding. A significant 
increase of CD40L+ CD4+ T cells in the peripheral 
blood mononuclear cells (PBMCs) of patients with active 
lupus was detected. In addition, CD8+ T cells and B 
cells from these patients showed a de novo expression of 
CD40L. Utilization of a blocking monoclonal antibody 
against CD40L impressively inhibited production of the 
antinuclear autoantibodies in the patients (Desai-Mehta 
et  al. 1996). In the advanced stages of lupus nephritis, 
increase of CD40 in the parenchymal and non-parenchy-
mal cells of kidney was detected (Yellin 1997). A compre-
hensive summary of the literature on the CD40L role in 
SLE has been described by Yazdany et  al. (Yazdany and 
Davis 2004).
Infiltrated CD40L+ T cells were detected in the lesions 
of multiple sclerosis (MS) patients (Gerritse 1996; Jensen 
et al. 2001). Analysis of CD40 and CD40L expression in 
the experimental autoimmune encephalomyelitis (EAE), 
the animal model of MS, showed upregulation of these 
molecules during clinical attacks (Gerritse 1996). Mono-
cytes, macrophages and activated microglia were found 
to be the major cells expressing CD40 in MS patients. 
Besides, the endothelial cells expressed CD40 either 
in a constitutive or inducible manner (Wheway et  al. 
2013; Aarts 2017). CD40 activation of endothelial cells 
resulted in the expression of adhesion molecules, includ-
ing E-selectin, vascular cell adhesion protein 1, and 
intercellular adhesion molecule 1. Accordingly, T cell 
adhesion to the endothelial cells was increased, facilitat-
ing the migration of T cells across the blood–brain bar-
rier into the central nervous system (CNS) (Omari and 
Dorovini-Zis 2003). Pathologic activation of microglia, 
resident macrophages of the brain, was shown to be 
associated with chronic inflammatory diseases, includ-
ing MS (Luo 2017). It was shown that microglia stimu-
lated with CD40L generate an inflammatory milieu in 
the brain through upregulation of TNF-α, interleukin-12 
(IL-12), nitric oxide, matrix metalloproteinase 9 (MMP9) 
and monocyte chemoattractant protein 1 and C-X-C 
motif chemokine 10 (Aarts 2017; D’Aversa et  al. 2002). 
A comprehensive review of the implication of CD40-
CD40L axis in MS and animal models of the disease has 
been performed by Aarts et al. (2017). Lamina propria T 
cells isolated from the patients with inflammatory bowel 
diseases (IBDs), including Crohn’s disease and ulcera-
tive colitis, expressed a high level of CD40L molecules 
and were able to enhance the production of IL-12 and 
TNF-α from monocytes. Activated T cells from IBDs 
patients also produced a prolonged expression of CD40L. 
Moreover, a higher number of CD40 + cells, includ-
ing macrophages and B cells, was found in the inflamed 
mucosa of the patients compared to the healthy control 
individuals (Liu et al. 1999). Besides macrophages and B 
cells, endothelial cells from the lamina propria vascula-
ture upregulate CD40, facilitating infiltration of CD40L 
expressing T cells into the tissues (Danese et  al. 2006). 
The higher percentage of CD40+ cells in the colonic 
mucosa of IBDs patients found to be directly associated 
with the disease activity (Polese 2002).
Analysis of naïve T cells and B cells from healthy 
women showed biallelically expressed CD40L gene 
at least in some cells compared to healthy men 
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lymphocytes. Female B cells of SLE patients also exhib-
ited biallelic expression of CD40L gene as well as 
increased expression level providing evidence in reactiva-
tion of immune-related gene CD40L in SLE female lym-
phocytes and consequent enhanced immune response in 
the female patients (Wang 2016). Consistently, stimulated 
PBMCs from healthy females and males with Klinefel-
ter syndrome, men with XXY karyotype, showed higher 
CD40L expression level in T cells and higher number 
of Cluster of differentiation 3 (CD3)+  CD40L+ T cells 
compared with healthy males and women with  Turner 
syndrome, women with X karyotype (Sarmiento et  al. 
2019). Coz et al. identified a CD40L gene duplication in 
CD4+ T cells of a six-month-old male showing autoim-
mune disease, resulted in a twice CD40L gene transcripts 
than that of his unaffected relatives. These CD4+ T cells 
derived more expression level of activation-induced cyti-
dine  deaminase (AIDCA) in B cells resulting in more 
antibody class-switching and lower level of IgM antibody. 
Interestingly, CD4+ T cells of his mother which showed 
epigenetic silencing of the duplicated X chromosome, 
intermediately induced AIDCA expression and antibody 
class-switching than those of female healthy controls 
and her son (Coz 2018). A higher level of IgG antibody 
was also recognized in female collagen-induced arthritis 
model of rheumatoid arthritis compared to male animal 
model of the disease by Dimitrijevice et al. Accordingly, 
a higher frequency of CD40L+ T cells and CD40+ B 
cells were identified in female lymph nodes of the ani-
mals compared to male counterparts (Dimitrijević 2020). 
Demethylation and increased expression of CD40L gene 
on the inactive X chromosome in female CD4+ T cells 
than male lymphocytes was also reported in patients 
with SLE (Lu et al. 2007). Altogether, these studies point 
to the contribution of CD40L gene in female bias of 
autoimmunity.
Cluster of differentiation 99 (CD99)
CD99 is a highly O-glycosylated transmembrane pro-
tein (type 1) which is not belonged to any of the known 
protein superfamilies. It exerts a fundamental function 
in the transendothelial migration of leukocytes known 
as diapedesis (Sullivan and Muller 2014). A hemophilic 
interaction between CD99 molecules located on mono-
cytes, neutrophils and lymphocytes with those of the 
endothelial cells, triggers a signaling cascade allowing 
migration of leukocytes towards the tissues across the 
tight junctions of endothelial cells (Sullivan and Mul-
ler 2014; Schenkel et al. 2002; Dufour et al. 2008; Bixel 
2004). A detail of the molecular mechanisms mediat-
ing diapedesis was given by Hichey el al (Hickey 2015). 
CD99 also implicated in the transmigration of DCs 
from peripheral tissues into the secondary lymphoid 
organs, where they present the captured antigens to the 
naive T cells and activate or enhance T cell responses 
(Torzicky 2012). Moreover, CD99 was identified for its 
function in the firm adhesion of resting and memory 
T cells to the vascular endothelium through increas-
ing affinity/avidity of α4β1 integrins. Firm adhesion is 
a central step in the leukocyte migration from blood 
into the tissues mediated through the integrins with the 
high-affinity binding state (Bernard 2000). CD99 activ-
ity in increasing affinity/avidity of the integrins, may 
be redundant or strengthen the similar effect exerted 
by the chemokines, resulting in the conversion of an 
integrin from a bent shape (low-affinity integrin) into 
the extended shape (high-affinity integrin) (Abbas et al. 
2017).
In addition to the role in the transendothelial migra-
tion of leukocytes, CD99 influenced cytokine production 
and antigen presentation. Ligation of CD99 on the acti-
vated T cells by a CD99 recombinant protein, increased 
production of proinflammatory cytokines, including 
interleukin-6 (IL-6) and TNF-α. Engagement of CD99 
on monocytes and natural killer cells also resulted in the 
increased production of IL-6 and TNF-α (Takheaw et al. 
2019). Waclavicek et  al. demonstrated resting T cells in 
response to CD99 stimulation and T cell receptor (TCR) 
activation, proliferate and produce IFN-γ and TNF-α, 
(Waclavicek 1998). A similar stimulatory role of CD99 for 
CD4+ T cells was reported by the others (Wingett et al. 
1999; Oh 2007). Furthermore, a CD99 requirement for 
the surface expression of MHC class I (MHC I) has been 
reported. Given that the extent of CD8+ T cell activation 
is dependent on MHC I densities presented on the cell 
surface of antigen presenting cells (APCs), the surface 
level of MHC I molecules is tightly regulated. Assuming 
CD99 acts as a mechanism for regulation of the surface 
MHC I densities, therefore, any CD99 perturbation may 
affect the expression level of MHC I and consequent 
CD8+ T cell activation (Brémond 2009; Sohn, et  al. 
2001). T cell activation by the above mentioned mecha-
nisms, contributes to the pathogenesis of autoimmune 
diseases being promoted mainly through T cell immune 
responses (Dardalhon et al. 2008; Skapenko et al. 2005).
On the contrary to the immunostimulatory functions of 
CD99, ligation of CD99 on plasma cells (PCs) interfered 
with the chemotactic translocation of PCs toward C-X-C 
motif chemokine 12 (CXCL12) chemokine (Gil 2015). 
CXCL12 directs migration of long-lived PCs towards the 
bone marrow, where the signals from the stromal cells 
provide the necessary microenvironment for the long 
survival of PCs (Abbas et al. 2017). Therefore, a high level 
of CD99 may be in favor of the antibody-mediated auto-
immune diseases (Mahévas et al. 2013), as a reduction in 
the number of autoreactive long-lived PCs is expected. 
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However, additional studies are necessary to address this 
issue.
Other studies unrevealed a possible etiology of the con-
tradictory roles of CD99 (Cernadas et  al. 2009; Alberti 
2002). Cernadas et  al. identified a regulatory role for 
CD99 in the expression of cluster of differentiation 1a 
(CD1a) in which isoform variants of CD99 possess oppos-
ing effects on the CD1a expression in human monocyte-
derived DCs. While CD99 long-form decreased CD1a 
transcription, the short-form of CD99 counteracted 
this effect (Mahiddine 2016). Basically, CD1a molecules 
which are structurally similar to MHC I, are known for 
their functions in the presentation of lipid and glycolipid 
antigens to gamma delta T cells. DCs expressing CD1a 
produces a great amount of IL-12 and promotes T helper 
1 (Th1) responses in favor of some autoimmune diseases 
(Cernadas et  al. 2009). Therefore, CD1a acquisition in 
DCs may be accompanied with obtaining a functional 
trait and CD99 regulates DCs function through control-
ling CD1a expression. As a conclusion, different isoforms 
of CD99 molecules may be responsible for the various 
effects exerted on the immune responses by CD99.
In psoriasis, the disease progression was accompanied 
by the elevated CD99 protein in the dermis and epider-
mis. On the other hand, a decrease of CD99 protein in 
both dermis and epidermis, was observed in the remis-
sion phase of the disease (Belonogov and Ruksha 2013). 
An increase in the CD99 expression level in the PBMCs 
and inflamed mucosa tissues obtained from the patients 
with IBDs was reported Zhou et  al. The level of CD99 
molecules was positively associated with the disease 
activity. These results suggested CD99 may play a patho-
logic role in the disease course of IBD and serves as an 
indicator of the disease activity in the patients (Zhou 
et al. 2017). CD99 inhibition in the animal model of MS, 
EAE, reduced leukocytes infiltration, including CD4+ T 
cells, CD8+ T cells and B cells into the CNS and attenu-
ated the disease in the animals (Winger et  al. 2016). In 
conclusion, despite the divergent effects of CD99 on the 
immune responses, the insights coming from the human 
autoimmune diseases and animal models of autoimmune 
diseases, support the pathologic roles of CD99 in auto-
immunity. In addition, further experiments are required 
to evaluate contribution of CD99 in the female bias of 
autoimmunity.
Lysosome‑associated membrane protein 2 
(LAMP‑2)
LAMP-2 is a highly glycosylated type I transmembrane 
protein with a molecular weight of about 40–45  kDa 
for the protein backbone and a total molecular weight 
of approximately 120  kDa for its glycosylated protein. 
Both LAMP-2 and LAMP-1 constitute around 50% of the 
lysosome membrane proteins. They were proposed to be 
responsible for keeping the lysosomal membrane integ-
rity against the hydrolytic enzymes located whiten the 
lysosome lumen. The overall structure of LAMP-2 con-
tains an amino-terminal lumenal domain, a transmem-
brane domain and a carboxy-terminal cytosolic domain.
Alternative splicing of the primary messenger ribo-
nucleic acid (mRNA) of LAMP-2 generates various iso-
forms, including LAMP-2a, LAMP-2b, and LAMP-2c 
which are different in the amino acid sequences of the 
transmembrane and cytosolic domains (Eskelinen 2006). 
It was shown that LAMP-2a isoform is different in its 
structural and functional properties from the other iso-
forms. In this regard, LAMP-2a involves in the autophagy 
process mediated by chaperons, called Chaperon medi-
ated autophagy (CMA). In CMA, misfolded cytoplasmic 
proteins are recognized and targeted by the chaperons 
for the degradation in lysosomes (Cuervo and Dice 2000; 
Kaushik and Cuervo 2012). Herein, 70 KDa heat shock 
cognate proteins (Hsc70) recognize the cytoplasmic 
proteins containing the amino acid sequence of KFERQ 
and deliver them to the lysosomal membrane recep-
tor, LAMP-2a. After binding of the substrate proteins to 
LAMP-2a, LAMP-2a is multimerized, facilitating unfold-
ing of the substrate proteins and their translocation into 
the lysosomal lumen. The modulation of the LAMP-2a 
level is a way by which the cells regulate the extent of 
CMA (Kaushik and Cuervo 2012).
Antigen presentation is a vital process for the activation 
of T lymphocytes in which a protein (or autoantigen) is 
degraded, and the resulting linear epitopes bind to MHC 
molecules and presented on the surface of APCs to be 
recognized by T cells (or autoreactive T cells). Classically, 
it is well known the endogenous cytoplasmic proteins 
are loaded on MHC I molecules and present to CD8+ T 
cells, while the exogenous proteins are loaded on MHC 
class II (MHC II) molecules and present to CD4+ T cells. 
The degradation of the endogenous and exogenous pro-
teins is performed in the proteasomes and lysosomes, 
respectively (Abbas et al. 2017).
Autophagy enhances presentation of the endogenous 
antigen on MHC I and activates CD8+ T cells activation. 
Moreover, it was recognized that the endogenous pro-
teins (cytosolic autoantigens) derived from autophago-
somes can be loaded on MHC II and activate CD4+ T 
cells (Zhou 2005). These findings highlight the possible 
roles of LAMP-2a in the antigen presentation to autore-
active T cells through CMA leading to the initiation or 
enhancement of immune responses against autoantigens. 
An impairment in the exogenous antigen presentation 
on MHC II molecules in the LAMP-2 deficient B cells 
was also reported, providing a direct evidence for the 
contribution of LAMP-2 in priming and activation of T 
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cells against the antigens (Crotzer et al. 2010), however, it 
remains to be discovered whether LAMP-2 contribution 
in the antigen presentation to T cell is mediated through 
regulation of the autophagy machinery or by a direct 
influence on the components involved in the pathway of 
antigen presentation on MHC molecules.
In addition to affecting antigen presentation, autophagy 
is implicated in the activation of NF-κB. NF-κB is a cen-
tral transcription factor in the transcription of the genes 
involved in innate and adaptive immune responses such 
as proinflammatory mediators, adhesion molecules and 
chemokines (Liu et al. 2017). Dysregulation of the NF-κB 
pathway has been demonstrated in many autoimmune 
diseases and the pathway components have been consid-
ered as the potential therapeutic targets in inflammatory 
and autoimmune diseases (Tak and Firestein 2001; Her-
rington et  al. 2015; Bacher and Schmitz 2004). Criollo 
et  al. uncovered autophagy is needed for NF-κB activa-
tion. They showed stimulation of autophagy removes the 
inhibitory effect of inhibitor of NF-κB which acts as the 
inhibitor of NF-κB activation (IκB). Therefore, NF-κB is 
activated and migrate into the nucleus, where it upregu-
lates expression of the genes involved in the inflamma-
tory response (Criollo 2010). Accordingly, Kanayama 
et al. showed the enhanced activation of NF-κB in mac-
rophages by autophagy. Activation of autophagy led to 
the degradation of A20 which negatively regulates NF-κB 
gene expression (Heyninck 1999; Kanayama 2015).
Autophagy also affects T cell proliferation, survival and 
differentiation. Deficient T cells in the autophagy genes 
show impaired proliferation and increased level of apop-
tosis. Khan et al. observed that costimulation of nucleo-
tide-binding oligomerization domain-containing protein 
2 and toll-like receptor 4 in DCs induced autophagy 
genes and increased production of the cytokines, includ-
ing IL-6, IL-12 and IFN-γ and costimulatory molecules, 
CD40, CD80 and CD86, in T cells. These results sug-
gested autophagy participates in the induction of Th1 
responses (Khan 2016). In another study, the role of 
autophagy in the induction of both IFN-γ and inter-
leukin-17 (IL-17) cytokines and inhibition of T helper 
2 (Th2) responses was identified (Reed et  al. 2013). In 
the concept of autoimmunity, autophagy may increase 
the proliferation and survival of autoreactive T cells. In 
addition, it increases the differentiation of Th1 and Th17 
which are implicated in the pathogenesis of many auto-
immune diseases (Dardalhon et al. 2008; Skapenko et al. 
2005). The humoral immune response is also influenced 
by autophagy. It was shown that autophagy participates 
in B cell survival during developmental stages (Miller 
2008). In addition, it is required for the antibody pro-
duction by plasma cells, maintenance of plasma cell and 
long-lived humoral immunity (Pengo 2013).
The above mentioned mechanisms may somewhat 
explain the contribution of autophagy in the pathogene-
sis of some autoimmune diseases. Clark et al. found acti-
vation of autophagy in B cells in various developmental 
stages in a lupus mouse model and the human disease 
(Clarke 2015). Accordingly, the levels of autophagic tran-
scripts were positively associated with the disease activity 
and anti-double stranded DNA antibodies (anti-dsDNA) 
levels in the PBMCs of SLE patients (Wu 2017). Next 
studies should address contribution of LAMP-2 in the 
female bias of SLE.
In RA, a higher expression level of autophagy genes 
in the synovial tissues of the patients was observed. A 
direct correlation between these transcripts levels and 
the serum features of disease activity, including C-reac-
tive protein, erythrocyte sedimentation rate, anti-cyclic 
citrullinated peptide antibodies and rheumatoid factor 
was also observed (Zhu 2017). Accordingly, Loosdregt 
et al. observed the enhancement of autophagy in CD4+ 
T cells from RA patients. Inhibition of the autophagy in 
the mouse model of RA, reduced disease incidence and 
severity (Loosdregt 2016).
The disease severity in the mouse model and human 
disease of MS was associated with the transcriptional and 
protein levels of an autophagy gene, autophagy-related 
gene 5 (Alirezaei 2009). Another evidence in the partici-
pation of autophagy in MS, comes from the ameliora-
tive effect of rapamycin, an inhibitor of autophagy, in the 
relapsing–remitting EAE (Esposito 2010).
Besides immunoenhancing effects of autophagy, it also 
negatively affects the immune responses through inter-
fering with NF-κB activation, maturation and migration 
of DCs and activation of Tregs (Ghislat and Lawrence 
2018; Paul et al. 2012; Zang 2016). These may explain the 
reported protective roles of autophagy in autoimmunity 
(Bhattacharya et al. 2014). A comprehensive review of the 
literature on the implication of autophagy in autoimmun-
ity, was discussed by Yin et al. and Yang et al. (Yin, et al. 
2018; Yang et al. 2015a).
Interleukin‑1 receptor‑associated kinase‑1 (IRAK‑1)
IRAK-1 is a serine-threonine kinase involved in the 
signaling pathway of toll-like receptors (TLRs) and 
interleukin-1 (IL-1) receptors. It consists of (1) an amino-
terminal domain designated death domain which medi-
ates IRAK-1 interaction with IRAK-4 which is another 
serine-threonine kinase associated to the TLR and IL-1 
receptors (2) a carboxy-terminal domain which mediates 
IRAK-1 interaction with TRAF-6 (3) a kinase domain 
which mediates kinase activity of IRAK-1 resulting in the 
phosphorylation and activation of TRAF-6 (4) a proline–
serine–threonine-rich domain (Hynes and Nair 2014; 
Rhyasen and Starczynowski 2015).
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In the signaling pathways of TLRs and IL-1 receptors, 
engagement of the receptors with their ligands, includ-
ing TLR ligands and cytokines, activates a number of the 
downstream adaptor proteins and kinase proteins result-
ing in the activation of NF-κB transcription factor. The 
signaling cascade is initiated by the recruitment of mye-
loid differentiation primary response 88 (MyD88) to the 
cytoplasmic toll/IL 1 receptor domain of the receptors, 
followed by the association of IRAK-4 to the receptor. 
Thereafter, IRAK-1 is recruited and activated, leading to 
the phosphorylation and activation of TRAF-6. TRAF-6, 
in turn, activates IκB kinase (IKK) complex. This triggers 
dissociation of the IκB complex from NF-κB, followed by 
the NF-κB activation and its translocation to the nucleus, 
where it upregulates transcription of the genes involved 
in the activation of immune responses (Cooke et  al. 
2001).
Activation of NF-κB in macrophages, initiates tran-
scription of various genes cooperating to elicit and 
amplify inflammation including pro-inflammatory 
cytokines, TNF-α, interleukin-1 beta (IL-1β), IL-6 and 
IL-12, as well as lipid mediators, prostaglandins and leu-
kotrienes and chemokines. (Abbas et al. 2017).
Inhibition of NF-κB activation prevented DCs matu-
ration through downregulation of MHC molecules and 
costimulatory proteins (Rescigno et al. 1998; Hernandez 
2007; Albrecht et  al. 2008). NF-κB activation in T cells 
also modulates immune responses through affecting dif-
ferentiation of naïve T cells towards Th1, Th2 and Th17 
(Aronica, et  al. 1999; Li-Weber et  al. 2004; Ruan 2011). 
A valuable detail of the literature for NF-κB roles in T 
cell differentiation was given by Oh et al. (Oh and Ghosh 
2013). As a conclusion, IRAK-1 contribute to autoim-
munity through promoting differentiation and activation 
of various T cells subsets.
On contrary, NF-κB was reported to maintain toler-
ance and prevent autoimmunity. It participates in the 
development of natural Tregs in the thymus and sup-
ports the maintenance and functions of Tregs (Oh and 
Ghosh 2013; Sun et al. 2013). Besides, by controlling the 
functional maturation of DCs, NF-κB keeps DCs in the 
tolerogenic state and prevents activation of autoreactive 
T cells (Dissanayake 2011).
Several researchers documented the epigenetic altera-
tion of the target genes by IRAK-1. Differential methyla-
tion of 245 CpG sites in DNA of the stimulated T cells 
from SLE patients in comparison with the healthy indi-
viduals was reported which was mostly concentrated in 
MHC and interferon response l loci (Woodman 2013). 
Accordingly, Koelsch et  al. revealed methyl CpG bind-
ing protein 2/IRAK-1 loci affected genetic loci of MHC 
and interferon-regulated genes in the SLE patients 
through several epigenetic mechanisms, including DNA 
methylation, microRNA expression and histone modifi-
cations (Koelsch 2013).
Polymorphism studies revealed some allelic variants 
of IRAK-1 are associated with the higher risk of autoim-
munity (Li 2015). Certain allelic variants of IRAK-1 were 
associated with the increased risk of autoimmune thyroid 
diseases, including Hashimoto’s thyroiditis and Graves’ 
disease (Song 2015). rs3027898 C/A variant allele of 
IRAK-1 was found to be associated with the susceptibility 
to RA (Zhang 2013). IRAK-1 can contribute to the patho-
genesis of RA through modulation of tissue remodeling 
enzymes. It was demonstrated IRAK-1 induces matrix 
metalloproteinase 13 (MMP13) generation from human 
chondrocytes in response to IL-1 stimulation (Ahmad 
et al. 2007). MMP13 degrades collagen and aggrecan and 
contributes to the cartilage destruction in RA (Burrage 
et al. 2006).
IRAK-1 gene was identified as a crucial risk gene in the 
pathogenesis of SLE (Jacob 2009; Dieudé 2011). Besides, 
polymorphisms of another gene encoding A20-binding 
inhibitor of NF-κB1 (ABIN1) also predispose to SLE 
and other autoimmune diseases. ABIN1 which is a poly-
ubiquitin binding protein, acts as an inhibitor of NF-κB 
signaling pathway. Prevention of ABIN1 polyubiquitin 
binding resulted in the activation of NF-κB and conse-
quent inflammatory response (G’Sell et al. 2015). Accord-
ingly, the genetically modified mice expressing a mutant 
of ABIN1 in which polyubiquitin binding region of the 
protein was defective, generated an autoimmune disease 
similar to the lupus nephritis. Suppression of IRAK-1 
in these animals prevented lupus nephritis suggesting 
IRAK-1 is a downstream target of the regulatory action 
of ABIN1 in the NF-κB signaling pathway and pertur-
bation of IRAK-1 expression may counteract the inhibi-
tory action of ABIN1 in NF-κB activation (Nanda et  al. 
2016). Upregulation of IRAK-1 in both transcriptional 
and protein levels was detected in SLE patients. Inhibi-
tion of IRAK-1 in naïve T cells from the SLE patients 
prevented Th17 differentiation. Therefore, IRAK-1 may 
contribute to the SLE pathogenesis through expanding 
Th17 responses (Zhou 2018). Chiang et al. provided evi-
dence elucidating another mechanism of IRAK-1 contri-
bution to the SLE pathogenesis. They found inhibition of 
IRAK-1 (and IRAK-4) differentially influenced activation 
of various immune cells in response to TLR7 or TLR9 
stimulation. IRAK1 inhibition prevented plasmacytoid 
dendritic cells (pDCs) activation, not the other human 
immune cells (Chiang et  al. 2011). It is known activa-
tion of pDCs by self DNA and RNA, triggers production 
of IFN-α which is implicated in the SLE pathogenesis 
(Sisirak 2014). Therefore, IRAK1 may be involved in the 
SLE pathogenesis by activating pDCs. Elevated serum 
level of IFN-α in New Zealand hybrid mouse model of 
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SLE grafted with female hematopoietic cells rather than 
the male hematopoietic cells, points to the involve-
ment of IFN-α in female bias of SLE. As IRAK-1 gene is 
involved in the signaling pathway downstream of IFN-α, 
IRAK-1 gene may be considered as an essential factor in 
the female-dependency of SLE (David 2014). In another 
study, it was exhibited that female SLE T cells increased 
expression of IRAK1 and showed altered X chromosome 
inactivation pattern compared to the male SLE patients, 
while female healthy controls showed a similar expres-
sion profile of IRAK-1 to those of male SLE patients indi-
cating a sex-biased role of IRAK-1 in SLE disorder (Syrett 
et al. 2019).
A female-biased contribution of IRAK-1 in the patho-
geneses of experimental colitis, the experimental ani-
mal model of IBDs, was observed by Berglund et al. The 
male IRAK-1 deficient mice showed significant protec-
tion against the disease compared to the female IRAK-1 
deficient mice (Berglund 2009). IRAK-1 was shown to 
be vital for returning of the activated T cells into the 
inflamed intestine, after their priming in the peripheral 
lymphoid organs (Heiseke et al. 2015). It has been exhib-
ited the therapeutic intervention such as vesicles contain-
ing miR-146a, attenuate the experimental colitis in the 
animals by inhibition of TRAF-6 and IRAK-1 (Wu 2019).
The possible attribution of IRAK-1 in the pathogenesis 
of scleroderma, comes from the study in which inherited 
IRAK-1 deficiency in a boy resulted in the poor responses 
of his fibroblasts to the TLRs agonist (Della Mina 2017). 
TLRs stimulation by their corresponding ligands or ago-
nists participate in the disease pathogenesis through 
the activation of fibroblasts which promotes fibrosis of 
the surrounding tissues, the dominant characteristic 
observed in scleroderma patients (Bhattacharyya et  al. 
2017).
Toll‑like receptor 7 (TLR7)
TLR7 is an intracellular TLR located in the endosomes 
and lysosomes and binds single-stranded RNA (ssRNA). 
Moreover, it recognizes guanosine and oligoribonucleo-
tides containing uridine, which are the resulting prod-
ucts of ssRNA degradation in ribosomes (Miyake 2018; 
Fujiwara et al. 2017; Shibata 2016; Sarvestani 2014). Ini-
tial binding to the oligoribonucleotides is a prerequisite 
for guanosine binding (Miyake 2018; Shibata 2016). This 
dual binding may synergistically enhance activation of 
TLR7 (Miyake 2018; Shibata 2016). The crystallography 
of TLR7 represented a dimerized m-shaped structure 
for the receptor, containing two ligand-binding sites. 
The first site bound guanosine, and the second site was 
responsible for the recognition of uridine moieties in 
ssRNA and oligoribonucleotides (Zhang 2016).
Upon binding to the ligand, TLR7 activates and stimu-
lates the production of proinflammatory cytokines and 
chemokines, including TNF-a, IL-6, IL-12 and regulated 
upon activation, normal T cell expressed and secrete 
chemokine (C-C motif ) ligand 5 (CCL5), a chemokine 
which acts a chemotactic factor for T cells, eosinophil 
and basophil (Bishara et  al. 2012). The immunostimula-
tory functions of TLR7 are mediated through interferon 
regulatory factor 5, NF-κB and AP-1 transcription factors 
(Shevlin and Miggin 2014). Moreover, TLR7 activation 
triggers the production of type I IFNs via interferon regu-
latory factor 7 (IRF7) transcription factor. After TLR7 
activation, the receptor traffics from the endosomes and 
lysosomes towards the peripheral regions of the cell. ADP 
ribosylation factor like GTPase 8b (Arl8b) and pleckstrin 
homology domain-containing family M member 2 (Ple-
khm2) deficient pDCs are impaired in the TLR7 traf-
ficking suggesting Arl8b and Plekhm2 are the essential 
components of TLR7 trafficking machinery. In addition, 
a perturbation in type I IFNs production in the Arl8b and 
Plekhm2 deficient pDCs was observed indicating traf-
ficking of TLR7 to the cell periphery is required for the 
generation of type I IFNs by pDCs. Mechanistically, these 
proteins mediate cytoskeletal changes required for the 
organelle translocations across the cell. This allows for 
the movement of TLR7 vesicles towards the periphery, 
where the IRF7 transcription factors are located. After-
wards, IRF7 are activated and enhance transcription of 
type I IFNs. The etiologic role of type I IFNs particularly 
interferon-alpha (IFN-α) in the pathogenesis of SLE has 
been well-known (Rönnblom and Alm 2001). In a study 
IFN-α was introduced as a new biomarker of the disease 
activity in SLE patients (Obermoser and Pascual 2010). 
Interestingly, a higher IFN-α production was detected in 
the females than the males after TLR7 stimulation, high-
lighting the role of TLR7 in the female-biased prevalence 
of SLE in women (Berghöfer, et al. 2006).
Self nucleic acids which activate TLR7, are delivered to 
the endosomal or lysosomal compartments through sev-
eral ways, including (Celhar et al. 2012): (1) Endocytosis 
of the immune complexes containing self nucleic acids 
and antibody after binding to Fc gamma receptors (FcγR) 
of the immune cells (2) Uptake of the complexes contain-
ing self nucleic acids and LL-37, a cationic antimicro-
bial inflammatory peptide which has been identified to 
facilitate the uptake of DNA and RNA into the cytoplasm 
(Pandey et  al. 2014) (3) Uptake of the complexes con-
taining self nucleic acids and high mobility group box 1, 
a chromatin-binding protein which is released upon the 
cell death and serves as a damage-associated molecular 
pattern molecule eliciting the immune responses (Yang 
et al. 2015b) (4) Uptake of neutrophil extracellular traps, 
the structures containing DNA, histones and granule 
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proteins of neutrophils released from the cell upon its 
activation and contributes to the microbial killing (Li and 
Tablin 2018) (5) Uptake of apoptotic cell debris contain-
ing self-nucleic acids (Celhar et al. 2012).
Recently, age-associated B cells (ABCs) have been dis-
covered, which contribute to the autoimmunity. This sub-
set of B cells expressed T-box protein expressed in T cells 
transcription factor and accumulated with age (Rubtsova 
et  al. 2015). TLR7 signaling was identified to be crucial 
for the autoantibody production by the ABCs and the 
cell accumulation in the inflamed organs (Rubtsov et al. 
2013). Late apoptotic cell debris has been implicated in 
the production of autoantibodies in SLE (Jung and Suh 
2015). A prerequisite for TLR7 in the autoantibody pro-
duction, including anti-dsDNA and anti-histone antibod-
ies, was documented in the animal model of SLE after 
administration of the late apoptotic cell debris. TLR7 also 
promoted complement component 3 deposition in the 
glomerulus. These findings point to the pathologic role of 
TLR7 in the autoantibody production (Pan 2010). More-
over, robust activation of TLR7 generated and expanded 
spontaneous GCs in SLE through upregulation of cyclic 
D3 (CCND3) (Fan et  al. 2018; Ren 2016). CCND3 con-
tributes to the formation and expansion of GCs and its 
upregulation in SLE patients is associated with the pres-
ence of the remained apoptotic cells. The remained 
apoptotic cells are resulted from the impairment of the 
apoptotic cell death and decreased clearance of the apop-
totic cells in SLE patients. The rupture in the plasma 
membrane of the remained apoptotic cells releases intra-
cellular antigens such as self DNA and RNA (Colonna 
et al. 2014). Binding of the immune complexes containing 
self nucleic acid (self DNA and RNA) and autoantibody 
to the B cell receptors (BCR), triggers endocytosis and 
subsequent delivery of the self nucleic acid to the endo-
somal compartments resulting in the activation of TLR7 
signaling. As a result, the autoreactive B cells are acti-
vated and increase the expression of CCND3. CCND3, 
in turn, vigorously promotes B cells proliferation and 
GCs formation. In GCs, B cells actively continue to the 
production of autoantibodies (Fan et al. 2018; Soni, et al. 
2014). Enhanced TLR7 expression in B cells increases B 
cells sensitivity, polyclonal proliferation and differen-
tiation into the antibody-producing cells (Bekeredjian-
Ding, et al. 2005).
The high expression level of TLR7 in transient B cells 
renders them hyper-responsive to the BCR stimulant and 
TLR7 stimulation, which triggers production of a great 
amount of the antibodies, including anti-RNA antibod-
ies. Transient B cells are immature B cells migrated from 
the bone marrow into the spleen and ultimately develop 
to follicular B cells, the main subset of B cells which are 
involved in the humoral immune response against T 
dependent antigens (Loder 1999). These findings imply 
high TLR7 expression in the developmental stages of B 
cells renders them to an autoreactive phenotype (Giltiay 
2013).
Distinct expressions of TLR7 and TLR9 in SLE patients 
were associated with the distinct autoantibody patterns. 
The levels of autoantibodies, including anti-extractable 
nuclear antigens and anti-dsDNA antibodies, were cor-
related with TLR7 and TLR9 levels, respectively suggest-
ing the TLRs effect in directing the autoantibody profiles 
of SLE patients (Chauhan et al. 2013). TLR7 activation in 
neutrophils also influences immune complex-mediated 
autoimmune diseases such as SLE (Toong et al. 2011), as 
it triggered the breakdown of FcγRIIA (CD32) located on 
pDCs and monocytes. Given the involvement of FcγRIIA 
in the phagocytosis and clearance of immune complexes, 
FcγRIIA degradation interferes with the immune com-
plex clearance (Lood et al. 2017).
Besides affecting humoral immune responses, TLR7 
also influences T cell responses in autoimmunity. TLR7 
activation increased production of IL-12 from mac-
rophages of the patients with immune thrombocytopenia 
and promoted Th1 polarization resulting in the reduction 
of the platelet count (Yang 2011; Spranger 2010). Accord-
ingly, TLR7 deficient mice developed Th2 responses 
against influenza A virus, suggesting TLR7 inhibits Th2 
responses. Simultaneously, an accumulation of myeloid-
derived suppressor cells, the immunosuppressive cells of 
immune system with the myeloid origin, was found in the 
TLR7 deficient mice (Jeisy-Scott 2011). TLR7 activation 
also participates in Th17 differentiation and functions in 
pDCs (Yu, et al. 2010).
CD8+ T cells purified from the human immunodefi-
ciency virus-1-infected patients significantly activated 
in response to the TLR7 engagement, as evidenced by 
the expression of the activation markers and IFN-γ pro-
duction by CD8+ T cells, suggesting TLR7 activation 
in CD8+ T cells triggers their activation (Song 2009). 
In addition, an enhanced cross-presentation of the cell-
associated antigens to CD8+ T cells was observed using 
influenza A-infected cell lines in comparison with the 
uninfected cell lines, resulting in the dramatic expan-
sion and activation of CD8+ T cells. The increase in the 
cross-priming of CD8+ T cells was dependent on TLR7 
recognition of influenza A virus RNA (Wei et  al. 2010). 
Expanding these findings to the autoantigens, viral infec-
tion can trigger the onset or progression of autoimmune 
diseases, as the virus-infected DCs is more potent in the 
cross-priming of autoreactive CD8+ T cells due to the 
immunostimulatory effects of viral RNA in TLR7 acti-
vation (Getts et al. 2013). Altogether, these studies open 
the insights to the TLR7 functions in the activation of 
the cellular immune responses (both CD4+ T cells and 
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CD8+ T cells) and possible roles in the onset or promo-
tion of autoimmune diseases.
Ligation of TLR7 in DCs was accompanied by the 
upregulation of CD80, CD86, C-C chemokine receptor 
type 7 and CD40 molecules and production of IL-6 and 
IL-12, highlighting the role of TLR7 in DCs maturation 
and promotion of Th1 immune responses (Larangé et al. 
2009). TLR7 activation of DCs also promoted autoreac-
tive Th17 responses in the experimental autoimmune 
uveitis mice, leading to the exacerbation of the diseases 
(Xiao 2016). DCs stimulated with TLR7 ligands gener-
ated B -cell activating factor which is a major cytokine in 
the proliferation, differentiation and survival of B cell and 
enhanced activation of autoreactive B cell and produc-
tion of autoantibodies (Yu 2011).
Stimulated PBMCs from females and Klinefelter syn-
drome  patients exhibited significantly higher expression 
level of TLR7 compared to PBMCs from male and Turner 
syndrome patients (Sarmiento et al. 2019). Consistently, 
Souyris et al. demonstrated biallelic TLR7 gene in naïve 
B lymphocytes, monocytes, and plasmacytoid dendritic 
cells from healthy women and men with Klinefelter 
syndrome as well as a greater expression level of TLR7. 
Besides, these TLR7-stimulated biallelic B cells produced 
more than two-fold of IgG antibody than monoallelic B 
cells (Souyris, et al. 2018). Several studies demonstrated 
the contribution of TLR7 copy numbers to the female 
bias observed in autoimmunity, particularly in SLE 
(Sarmiento et al. 2019; Yu, et al. 2010; Liao 2014; García-
Ortiz 2010; Heintze 2018). Interestingly, a functional 
polymorphism in the TLR7 gene resulting in the elevated 
TLR7 expression, predisposed the male gender to SLE 
(Shen 2010) The Y-linked autoimmune accelerating (Yaa) 
locus which is located on the Y chromosome and con-
tains a cluster of the X-linked genes translocated into the 
Y chromosome, confers susceptibility to the autoimmune 
disease in male mice. TLR7 gene was identified in the Yaa 
locus and played a major role in the autoimmune pheno-
types of these mice manifested as the splenomegaly and 
glomerular nephritis accompanied with the perturbation 
of immune responses and leukocytes infiltration into the 
kidney (Fairhurst 2008; Pisitkun, et al. 2006). In a recent 
review by Souyris et al., contribution of TLR7 in female 
bias of autoimmunity has been comprehensively summa-
rized (Souyris et al. 2019).
TLR7 was shown to be involved in the exacerbation of 
EAE. The protection observed in the TLR7 deficient mice 
was manifested as the reduced level of autoantibodies, 
reduced activation of autoreactive T cells and elevation in 
Foxp3+ Tregs (Lalive 2014). In RA, a strong correlation 
between TLR7 expression in monocytes and proinflam-
matory cytokines level, TNF-α, was described (Chamber-
lain 2013).
In contrast to the stimulatory functions of TLR7 
in immune responses, its inhibitory effects were also 
reported. Dominguez-Villar et al. showed TLR7 ligation 
induces an anergic state in CD4+ T cells through activa-
tion of NFAT transcription factor. This may explain sig-
nificant dysfunction of CD4+ T cells observed during a 
chronic viral infection such as HIV, as genomic RNA of 
the virus constantly triggers TLR7 signaling (Dominguez-
Villar et  al. 2015; Lederman 2015). TLR7 signaling also 
increased the suppressive activities of CD4+ CD25+ 
Tregs which was a result of the increased sensitivity of 
Tregs to interleukin-2 (IL-2) activation, as IL-2 increases 
the survival and suppressive activities of Tregs (Forward 
et al. 2010). These immunosuppressive activities of TLR7 
may explain the attenuation of the disease in the EAE 
model, after treatment of the animals with the TLR7 ago-
nist (O’Brien et al. 2010).
Ubiquitin carboxyl‑terminal hydrolase 27 (USP27X)
USP27X is a deubiquitinating enzyme consists of 438 
amino acids and contains a conserved catalytic domain. 
It removes ubiquitin from the proteins (Guo et al. 2019). 
Ubiquitin is a small molecule (76 amino acids) which is 
added to a protein during a process called ubiquitination 
and marks the proteins for the degradation in proteas-
omes (Gong et  al. 2016). Dysregulation of USP27X was 
related to some cancers (Lambies 2019; Weber 2016). 
Given that the possible implication of USP27X in the 
autoimmunity has not been addressed in any studies, 
however, a hypothetical implication of USP27X in the 
autoimmunity can be deduced from the other studies.
USP27X removes ubiquitin from cyclic guanosine 
monophosphate (GMP)-adenosine monophosphate 
(AMP) synthase (cGAS) and decreases its turnover. 
cGAS recognizes cytosolic DNA and subsequently trig-
gers inflammatory response. After DNA sensing, cGAS 
promotes an enzymatic reaction resulting in the genera-
tion of cyclic GMP-AMP (cGAMP). cGAMP binds to the 
stimulator of interferon genes (STING) protein. Acti-
vated STING triggers phosphorylation of TANK binding 
protein 1 (TBK1). Consequently, phosphorylated TBK1 
activates interferon regulatory factor 3 (IRF3), a tran-
scription factor that is involved in the transcription of 
inflammatory genes particularly type I IFNs (Guo et  al. 
2019). Macrophages obtained from USP27X deficient 
mice showed impaired innate antiviral responses against 
Herpes simplex virus type 1 infection. Mechanistically, 
a reduction in the interferon-beta (IFN-β) production 
was observed in the macrophages accompanied with the 
decrease in cGAMP production, TBK1 phosphorylation 
and IRF3 activation (Guo et  al. 2019). The etiological 
role of type I IFNs, including IFN-β, in the pathogen-
esis of autoimmune diseases is well-known documented 
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(Rönnblom and Alm 2001). Accordingly, cGAS activation 
by self DNA was found to contribute to the etiopathology 
of autoimmune diseases (Gao 2015).
USP27X may also contribute to the autoimmunity 
through increasing cell death by apoptosis. Increased 
apoptosis has been implicated in the pathogenesis of a 
number of autoimmune diseases such as SLE (Munoz 
2008). Pro-apoptotic effects of USP27X are mediated 
through its binding to phosphorylated and ubiquitinated 
Bcl-2-like protein 11 proteins, also designated Bim, and 
dissociation of ubiquitin molecules from this protein 
(Weber 2016). Bim is a pro-apoptotic protein which upon 
activation induces apoptosis. Regulation of the Bim level 
may be mediated either in the expression level or by 
its degradation in the proteasome after ubiquitination 
(Sionov et  al. 2015). Deubiquitinating enzyme USP27X 
stabilizes Bim molecules by the removal of ubiquitin mol-
ecules. Accordingly, over expression of USP27X induces 
a pro-apoptotic activity in some of tumor cell lines, 
including melanoma and non-small cell lung cancer cells 
(Weber 2016).
It was identified USP27X activates fibroblasts through 
the deubiquitination and stabilization of snail family 
transcriptional repressor 1, a transcription factor which 
is involved in the fibroblast activation (Díaz 2018). Acti-
vated fibroblasts initiate and enhance angiogenesis 
through the generation of vascular endothelial growth 
factor, TGF-β and platelet-derived growth factor (New-
man et  al. 2011). Therefore, USP27X may contribute to 
the pathogenesis of autoimmune fibrotic diseases such as 
scleroderma (Gilbane et al. 2013).
DEAD‑box helicase 3 X‑linked (DDX3X)
DDX3X is a member of RNA helicases from DEAD-box 
family containing the conserved motif of Asp-Glu-Ala-
Asp (DEAD motif ). The family members are basically 
known for their functions in RNA metabolisms, includ-
ing RNA transcription, processing, splicing and trans-
lation (Cordin et  al. 2006). Recently, they have been 
identified as the immune sensors in innate immunity 
(Taschuk and Cherry 2020). Retinoic-acid inducible gene 
I, a cytosolic member of the pattern recognition recep-
tors, is the most well-known member of the family impli-
cated in the recognition of viral RNA in cooperation with 
two other proteins, including melanoma differentiation-
associated 5 and laboratory of genetics and physiology 2 
(An 2017).
Several recent studies addressed a role for DDX3X 
in the antiviral immune responses through induc-
tion of type I IFNs. Chicken DDX3X was detected to 
induce IFN-β through STING-TBK1-IRF7-IFN-β axis 
(a detail for this type of the signaling cascade has been 
presented in the DDX3X section. Moreover, DDX3X 
was able to increase generation of proinflammatory 
cytokine, including IL-1β, IL-6, and IL-8 as well as 
myxovirus resistance 1 and protein kinase R (Niu et al. 
2019), two of the most studied antiviral IFN-stimulated 
genes which are implicated in the antiviral response 
of IFNs (Schoggins 2014). Porcine DDX3X was also 
induced IFN-β expression. More investigations showed 
DDX3X is co-localized with TBK1 and IKK suggesting 
involvement of these proteins in the signaling path-
way of DDX3X (Chen 2014). Accordingly, fish DDX3X 
exerted an antiviral effect mediated through the acti-
vation of IRF3 and IRF7 transcription factors resulting 
in the production of IFN-β (Liu 2017). In addition to 
affecting IFN-β production, Samir et  al. observed the 
lower activation of the NLR family pyrin domain con-
taining 3 (NLRP3) inflammasome in the DDX3X defi-
cient bone marrow-derived macrophages. This finding 
indicated the contribution of DDX3X in the NLRP3 
inflammasome activation. Inflammasome activation 
stimulates inflammatory response through generation 
of the active IL-1β and interleukin-18 (Samir 2019).
Interestingly, a DDX3X dependent sex-biased activa-
tion of macrophages was detected in the macrophages 
exposed to Listeria monocytogenes infection. An 
approximate of 75% of the genes that transcriptionally 
altered upon the infection of the male wild-type mac-
rophages, was responded to the infection in the DDX3X 
deficient counterparts. On the other hand, none of the 
altered genes in the female wild-type macrophages, 
were induced upon the infection in the female DDX3X 
deficient macrophages. A reduction in the expression 
level of the cytokines, including IL-1, IL-6, IL-12 and 
TNF-α as well as the chemokines was observed in the 
DDX3X deficient infected macrophages. In accord-
ance with the previous studies, a reduction in the 
IFN-β level was also observed. The signaling path-
ways leading to the activation of IRF3/IRF7 and NF-κB 
transcription factors, were implicated in the cytokine 
production. Examination of DDX3X deficiency in the 
TLR signaling, exhibited an impaired response of the 
DDX3X deficient macrophages to the stimulation with 
TLRs agonist, including poly (I:C), TLR3 agonist, and 
lipopolysaccharide (LPS), TLR 4 agonist. Altogether, 
these findings suggest the implication of DDX3X in 
the TLR signaling and production of proinflammatory 
cytokines and chemokines (Szappanos 2018).
Despite the lack of information on the association 
between DDX3X and autoimmune diseases and accord-
ing to the current findings, the DDX3X may contribute 
to the pathogenesis of autoimmune diseases and female 
bias of autoimmunity; however, further studies are nec-
essary to address these issues.
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Chromosome X open reading frame 21 (CXORF21)
CXORF21 is an uncharacterized protein which has been 
recently identified as a candidate gene implicated in the 
female bias in SLE (Odhams 2019). A higher upregula-
tion of CXORF21 protein in LPS and IFN-γ-stimulated 
monocytes and IFN-α-stimulated B cells was detected in 
the females than the males. In addition, the binding sites 
for NF-κB, STAT1, STAT2, STAT3 and IRF3 transcrip-
tion factors were identified at the promoter of CXORF21 
suggesting transcriptional regulation of CXORF21 by 
the cytokines (Odhams 2019). Accordingly, Harris et  al. 
demonstrated CXORF21 implication in the female bias 
observed in SLE (Harris 2019). Interestingly, it was dem-
onstrated that CXORF21 gene was transcriptionally inac-
tive in the non-immune cells, whereas its transcripts were 
detected in the immune cells with the highest expression 
level in monocytes, neutrophils and IFN-α B cells. The 
magnitude of CXORF21 expression was higher in females 
than males (Odhams 2019). The authors in another study, 
reported the greater level of CXORF21 in the females 
immune cells than those of the males. An elevation in 
the CXORF21 protein was detected after TLR7 activa-
tion. In accordance, CXORF21 deficient monocytes were 
unable to increase the expression level of IFN-α follow-
ing TLR7 stimulation. Therefore, CXORF21 protein may 
be involved in the female bias of SLE, acting downstream 
of TLR7 and regulate production of IFN-α. Accordingly, 
co-localization of the CXORF21 protein with TLR7 was 
also observed by the others (Paul 2013; Wu et al. 2015). 
Moreover, the lower endolysosomal pH was observed in 
the APCs from the females than that of the males. This 
suggests CXORF21 may regulate the antigen presenta-
tion (Harris et al. 2019), as the lower endolysosomal pH 
is in favor of the antigen processing in the endolysosomal 
compartment and thus subsequent antigen presentation 
on the cell surface (Abbas et al. 2017).
X‑linked inhibitor of apoptosis protein (XIAP)
Apoptosis is a physiologic cell death in which DNA, 
RNA and organelles are degraded and packed into the 
small vesicles called apoptotic bodies. Apoptotic bodies 
are quickly clear from the body by macrophages. Apop-
tosis is triggered through two pathways mediated by the 
enzymes called caspases: (1) Extrinsic pathway in which 
activation of the death receptors, including Fas recep-
tor (CD95) and TNF receptor 2, triggers activation of 
caspase 8. (2) Intrinsic pathways in which the released 
cytochrome c from the membrane-ruptured mitochon-
dria triggers activation of caspase 9. Activation of the 
initiator caspases, including caspase 8 and 9, are followed 
by the activation of the effector caspases (caspase 3, 6 
and 7). The effector caspases activate a complex of the 
enzymes resulting in the degradation of DNA, cytoskele-
tal and nuclear proteins and formation of apoptotic bod-
ies (Elmore 2007).
Activation of the caspases is tightly regulated through 
the inhibitors of apoptosis (IAP) proteins. XIAP is the 
best characterized protein of IAPs family and contains 
three Baculovirus IAP repeat (BIR) domains and a new 
gene finger domain. The BIR domains are responsible for 
the interaction of XIAP with several caspases and inhibi-
tion of their activation. The BIR2 domain is known to be 
involved in the interaction with caspase 3 and 7, whereas 
the BIR3 domain is implicated in the binding to cas-
pase-9. The high level of XIAP was associated with the 
poor responses of the tumor cells to the chemotherapy 
and other treatments (Flanagan 2015; Schiffmann 2019). 
Due to its roles in the prevention of apoptosis, XIAP has 
been a target of the immunotherapy in various cancer 
cells (Abbas and Larisch 2020; Katragadda et  al. 2013; 
Holcik et al. 2001).
Autoimmunity may arise from the survival of autore-
active lymphocytes which are intended for the removal 
by the apoptotic death during central or peripheral tol-
erances. Autoreactive lymphocytes which are generated 
during the developmental stages, differentiation or acti-
vation processes, are deleted or inactivated by various 
tolerance mechanisms either in the central lymphoid 
organs (central tolerance) or in the peripheral organs 
(peripheral tolerance) (Abbas et al. 2017). Apoptosis plays 
a fundamental role in the deletion of autoreactive lym-
phocytes, therefore, any defects in this process contribute 
to the development of autoimmune diseases. Moreover, 
the activated lymphocytes massively expanded in the 
response to the antigens (or autoantigens), intended to be 
died by the apoptosis to keep the immune responses in 
the homeostatic state (Abbas et al. 2017).
XIAP deficient patients showed more apoptosis rate 
in their lymphocytes after receiving stimulator signals, 
including the activators of TCRs (anti-CD3), Fas recep-
tors (anti-CD95), and TNF-related apoptosis-inducing 
ligand (TRAIL) receptors (tetrameric TRAIL molecules) 
(Rigaud 2006). In EAE, the animals overexpressed XIAP 
showed a severer form of the disease in comparison with 
the wild type animals which was associated with the 
resistance of T cells to the apoptosis (Moore 2008).
Despite using various stimulators of apoptosis for the 
induction of apoptotic cell death in the synovial tissues 
obtained from the patients with active RA, an inhibition 
in the cell death was observed. The phenomenon was 
associated with the elevated expression level of XIAP 
(Dharmapatni 2009). Synovial fluid´s lymphocytes of the 
patients with juvenile idiopathic arthritis also demon-
strated a resistance to the apoptosis which was associated 
with the elevated level of XIAP (Smolewska et al. 2006). 
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Therefore, XIAP can assist in the pathogenesis of auto-
immune diseases. Female SLE T cells showed increased 
expression of XIAP compared to male SLE patients and 
female healthy controls suggesting a female-biased role 
of XIAP in SLE disease (Syrett et al. 2019). Interestingly, 
sex dimorphism in cerebral ischemia with a tendency 
towards female gender was attributed to XIAP (Dai and 
Ahmed 2014).
Conclusion
Though XCI is applied to equalize the impact of two X 
chromosomes in females, however, some genes escape 
from XCI. The current literature provides evidence in 
the contribution of a number of the escape genes, includ-
ing CD40L, CD99, LAMP-2, IRAK-1, TLR7, USP27X, 
DDX3X, CXORF21 and XIAP, in the autoimmunity. 
Reviewing present literature for the contribution of 
some escapes genes including CD40L, IRAK-1, TLR7, 
CXORF21 and XIAP confirms their primary attribu-
tions to the female bias of autoimmune diseases espe-
cially SLE disease. However, more studies are required to 
evaluate contribution of these genes in the female bias of 
SLE using animal model of the disease and the efficacy 
of therapeutic interventions against these molecules for 
example using monoclonal antibodies. In addition, next 
experiments are necessary to address attribution of these 
genes to the female bias of other autoimmune diseases 
rather than SLE. Finally, investigating role of the other 
escape genes such as USP27X and DDX3X in the sex-bias 
of autoimmune diseases such as SLE, RA, MS may help 
to discover further mechanisms involved in the female 
bias of autoimmunity and consequently in developing 
more effective treatments and sensitive diagnostics of 
patients with autoimmune diseases.
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